Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: INTS) Delayed: 4.11 +0.23 (5.93%)
Previous Close $3.88    52 Week High
Open $3.79    52 Week Low
Day High $4.29    P/E N/A 
Day Low $3.79    EPS
Volume 45,214